<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <fn fn-type="financial-disclosure">
  <p>
   <bold>Funding.</bold> This work was generously supported by the GALVmed organization (recombinant virus construction, selection, and characterization) (under grant no. 710/CAP/07/003) and the Canadian International Development Research Centre in collaboration with Global Affairs Canada, within the Canadian International Food Security Research Fund (CIFSRF) Grant no. 107848-002 (cattle trial). IDRC have also kindly agreed to pay the APF.
  </p>
 </fn>
</fn-group>
